My Companies
Notification
Account
Log Out
Login
Allotted 83.64 lakh rights shares on 3 Nov — 75.03 lakh fully paid at Rs15 and 8.61 lakh partly paid at Rs3.75 — taking paid-up capital to Rs53.25 crore with BSE basis approval 2 Nov. Context: well short of planned recapitalisation leaving working-capital shortfall.
Indrayani Biotech ITAT Quashes ₹13.90 Crore Tax Demand Appellate Order
Indrayani Biotech Postpones Rights Issue Indefinitely After Earlier Extensions